LitigationUSA
Alexion Secures Victory in Massachusetts Antitrust Case Over Soliris Patent Enforcement
A federal district court in Massachusetts granted judgment on the pleadings in favor of Alexion Pharmaceuticals, dismissing a putative class action accusing the company of anticompetitive conduct by enforcing allegedly fraudulently obtained patents on its drug Soliris. The court found that EmblemHealth, the plaintiff…
Tuesday, November 17, 2026